Compounds > beta-lactams

Page last updated: 2024-09-04

beta-lactams and Infections, Serratia

beta-lactams has been researched along with Infections, Serratia in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (11.11)	18.2507
2000's	5 (55.56)	29.6817
2010's	3 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bojkova, KD; Markovska, RD; Mitov, IG; Stoeva, TJ	1
Hu, Q; Hu, Y; Lin, X; Lv, H; Xu, X; Zhang, R	1
Hu, Z; Zhao, WH	1
Fatima, N; Malik, A; Rashid, M; Rizvi, M; Shukla, I; Siddiqui, S; Usman, A	2
Coll, P; de la Cruz, F; Garcillán-Barcia, MP; Mata, C; Mirelis, B; Miró, E; Navarro, F	1
Chen, G; Fukuchi, K; Hu, ZQ; Matsushita, K; Shimamura, T; Zhao, WH	1
Chen, HE; Cheng, KC; Chuang, YC; Ko, WC; Lee, CC; Yu, WL	1
Berry, V; Mizen, L; Woodnutt, G	1

Other Studies

9 other study(ies) available for beta-lactams and Infections, Serratia

Article	Year
Epidemiology and molecular characterization of extended-spectrum beta-lactamase-producing Enterobacter spp., Pantoea agglomerans, and Serratia marcescens isolates from a Bulgarian hospital. Microbial drug resistance (Larchmont, N.Y.), 2014, Volume: 20, Issue:2 Topics: Adult; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Bulgaria; Child; Conjugation, Genetic; Enterobacter; Enterobacteriaceae Infections; Hospitals; Humans; Microbial Sensitivity Tests; Pantoea; Plasmids; Serratia Infections; Serratia marcescens	2014
Emergence of Serratia marcescens isolates possessing carbapenem-hydrolysing β-lactamase KPC-2 from China. The Journal of hospital infection, 2016, Volume: 94, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; China; DNA, Bacterial; Ertapenem; Female; Genotype; Hospitals; Humans; Hydrolysis; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Polymerase Chain Reaction; Serratia Infections; Serratia marcescens; Thienamycins; Young Adult	2016
Identification of plasmid- and integron-borne blaIMP-1 and blaIMP-10 in clinical isolates of Serratia marcescens. Journal of medical microbiology, 2009, Volume: 58, Issue:Pt 2 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Conjugation, Genetic; Escherichia coli; Gene Transfer, Horizontal; Humans; Integrons; Microbial Sensitivity Tests; Plasmids; Promoter Regions, Genetic; Serratia Infections; Serratia marcescens	2009
Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay. Journal of infection in developing countries, 2009, Apr-30, Volume: 3, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Citrobacter; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Serratia; Serratia Infections	2009
Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay. Journal of infection in developing countries, 2009, May-01, Volume: 3, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Citrobacter; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Serratia; Serratia Infections	2009
In vivo transmission of a plasmid coharbouring bla and qnrB genes between Escherichia coli and Serratia marcescens. FEMS microbiology letters, 2010, Jul-01, Volume: 308, Issue:1 Topics: Aged; beta-Lactamases; beta-Lactams; Blotting, Southern; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Transfer, Horizontal; Genes, Bacterial; Genotype; Humans; Plasmids; Polymerase Chain Reaction; Quinolones; Serratia Infections; Serratia marcescens	2010
Characterization of imipenem-resistant Serratia marcescens producing IMP-type and TEM-type beta-lactamases encoded on a single plasmid. Microbiological research, 2007, Volume: 162, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Conjugation, Genetic; DNA Fingerprinting; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Transfer, Horizontal; Genotype; Humans; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Serratia Infections; Serratia marcescens; Transformation, Bacterial	2007
Institutional spread of clonally related Serratia marcescens isolates with a novel AmpC cephalosporinase (S4): a 4-year experience in Taiwan. Diagnostic microbiology and infectious disease, 2008, Volume: 61, Issue:4 Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Blood; Cluster Analysis; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Molecular Epidemiology; Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Serratia Infections; Serratia marcescens; Taiwan	2008
Simulation of human serum pharmacokinetics of cefazolin, piperacillin, and BRL 42715 in rats and efficacy against experimental intraperitoneal infections. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:7 Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Biological Availability; Cefazolin; Drug Therapy, Combination; Escherichia coli Infections; Humans; Infusions, Intravenous; Lactams; Male; Microbial Sensitivity Tests; Peritonitis; Piperacillin; Rats; Rats, Inbred Strains; Serratia Infections	1992